Biopharma & Biotech Analysts Chen & Kim, along with Dr. Berger, Cardiologist at Fairview Health Services discuss new and emerging treatments in cardiovascular disease and takeaways from the recently-held ACC (American College of Cardiology) 2023 on an Analyst/Industry conference call to be held on March 9 at 11 am. Webcast Link
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on MRK:
- Opko Health Surges as Merck Considers Deal
- Opko Health enters exclusive worldwide license agreement with Merck
- Sotatercept data supports bullish view of Merck cardio franchise, says Jefferies
- Merck cardiovascular franchise set for ‘resurgence,’ says Mizuho
- Gossamer Bio downgraded to Market Perform from Outperform at Raymond James